Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04)[...]
Lineage Cell Therapeutics Inc.
Quarterly report which provides a continuing view of a company's[...]
06/06/2022 | Press release | Distributed by Public on 06/06/2022 10:56
Please select the service you want to use:
Smartlinks | Legal & General Group plc | Company News | Public Companies | Multiline Insurance and Brokers | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | OTC Markets | BX Swiss | Tradegate Exchange | Turquoise | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Börse Berlin Equiduct Trading | Aquis Exchange | SIGMA X MTF
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact